SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-11-004060
Filing Date
2011-04-26
Accepted
2011-04-26 10:26:38
Documents
3
Period of Report
2011-06-15
Effectiveness Date
2011-04-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2203567zdef14a.htm DEF 14A 383885
2 G105663BCI001.GIF g105663bci001.gif GRAPHIC 55653
3 G105663BCI002.GIF g105663bci002.gif GRAPHIC 37118
  Complete submission text file 0001047469-11-004060.txt   513235
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-15006 | Film No.: 11779029
SIC: 2835 In Vitro & In Vivo Diagnostic Substances